Skip to main content

Peer Review reports

From: Lefamulin efficacy and safety in a pooled phase 3 clinical trial population with community-acquired bacterial pneumonia and common clinical comorbidities

Original Submission
1 Dec 2020 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
20 Jan 2021 Reviewed Reviewer Report
2 Feb 2021 Reviewed Reviewer Report
23 Feb 2021 Author responded Author comments - Elizabeth Alexander
Resubmission - Version 6
23 Feb 2021 Submitted Manuscript version 6
24 Feb 2021 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
17 Mar 2021 Editorially accepted
8 May 2021 Article published 10.1186/s12890-021-01472-z

You can find further information about peer review here.

Back to article page